Company Overview and News

1
International FX Perspective: Are U.S. Stocks Still Overbought?

2018-10-08 seekingalpha
Bollinger Bands, as a basic statistical tool, can be used to judge whether U.S. stocks are in over-bought or over-sold territory.
SPY

1

2018-10-07 seekingalpha
Bollinger Bands, as a basic statistical tool, can be used to judge whether U.S. stocks are in over-bought or over-sold territory.
SPY

60
3 Reasons to Stay Away From Bank of America Stock

2018-09-29 investorplace
“Winning” may be President Trump’s motto, but Bank of America (NYSE:BAC) isn’t feeling the warm and fuzzies. Last year sparked a stellar performance in BAC stock, with shares returning nearly 33% for jubilant contrarians. Though Trump had previously caused concerns, his business acumen apparently boosted market confidence once in office.
WFC WFCNP C SPY BAC JPM

66
General Motors Stock Has Support — Go Long

2018-09-04 investorplace
Despite so-called experts warning that the automobile industry is at “peak auto,” auto sales have remained strong for years. Consumers have been resilient with their love for cars. Tastes shift from year-to-year, but overall we all love our vehicles.
F SPY TSLA GM

6
S&P 500 on Track for Longest Bull Run: How to Trade With ETFs

2018-08-22 zacks - 2
With easing trade war fears and geopolitical tensions, the S&P 500 Index hit all-time high, surpassing the previous peak reached in late January this year. This makes the index on track for the longest bull run in history at 3,453 days on Aug 22 or more than nine years (read: High Beta, Momentum ETFs & Stocks to Trade in a Market Rally). The latest rally came on the back of surging corporate profits, booming economic growth and hopes that the United States and China could resolve their trade dispute.
STT VOO SPXL SPY SPUU IVV AAPL MSFT IVV SSO

7
Global ETFs' AUM Rises to $5.1 Trillion in July: What's Hot?

2018-08-16 zacks - 1
Amid both peaks and troughs, the ETF industry is seeing explosive growth thanks to its unique strategies, creativity, transparency, diversification benefits, enhanced tax competences, low turnover and of course low cost. Additionally, the novel concept that issuers are bringing in to the ETFs is attracting investors. That said, the industry has reached to new high of $5.12 trillion in AUM. As per ETFGI, global ETFs have gathered around $41.
HD BBJP EWJ VTV IEMG SPY OXY

58
The Turkish Hamam Is Getting Too Hot For European Banks. Avoid The Bazaar!

2018-08-12 seekingalpha
Forty days ago we wrote about the impact that the slowing Brazilian economy has on Spanish banks.
BAC DB C BNPQY SPY BNPQF BVA SANT HCS BAC HSB BNPZY BNC 0005 TWTR HSEA HSEB HSBC SAN HBCYF

1
Real Estate Forward Indicator - Better Days Ahead For Builders?

2018-08-03 seekingalpha
A recently published forward indicator for housing offered an important change in trend for the better.
SPY

1
Outperforming The U.S. Market With The iM-Country Rotation System

2018-07-26 seekingalpha
The iM-Country Rotation System periodically selects one country ETF from six countries, USA, Canada, Japan, Australia, Germany and Sweden, based on the performance of their respective currency ETFs.
SPY

72
How The CARZ ETF Can Help You Hedge The Automobile Trade War

2018-07-17 seekingalpha
I analyze the effects of this hedging strategy in TSLA, WGO, and GM. GM is directly affected by the trade war, but TSLA and WGO are protected from it.
F SPY TSLA GM DMLRY WGO CARZ

3
Netflix: After The Close

2018-07-16 seekingalpha
Netflix has a huge presence in passive investing, ETFG's equity exposure reports shed light on potential movement within ETFs.
NEWR HD STT SPY NFLX FDN XLC

6
10 Best ETFs for 2018: Biotechs Top the Charts at the Midpoint | InvestorPlace

2018-07-11 investorplace - 1
The InvestorPlace Best ETFs for 2018 contest has officially hit its midway point, and we’re seeing some separation among the contestants. A few of the exchange-traded funds are struggling to reach breakeven while several are handily outpacing the S&P 500, as represented by the SPRD S&P 500 ETF (NYSEARCA:SPY). That fund garnered about 2% in the first six months.
SBIO QQQ SPY PHO QCOM

2
1H Asset Flow Roundup: What's Hot & What's Not

2018-07-03 zacks
Stocks across the globe have suffered their worst first half in a year since 2010, wiping out trillions of dollars from the MSCI’s 47-country world index. A combination of tariff tantrums, broad tech sell-off, the prospect of end to the cheap money era and cooling growth in many parts of the economy including Europe and Japan resulted in huge capital outflows from the market. Additionally, the strength in the U.
AGG IVV VEA SHV VOO SPY EZU IVV EFA FLOT EEM

14
Best ETFs for 2018: Energy Select Sector SPDR ETF Has Fuel for Second Half

2018-07-02 investorplace
This article is a part of InvestorPlace’s Best ETFs for 2018 contest. Kent Thune’s pick for the contest is the Energy Select Sector SPDR (NYSEARCA:XLE).
XOM CVX SPY SLB

23
May ETF Asset Report: U.S. Equities Rule

2018-05-31 zacks
Geopolitical tensions, oil price movement and President Trump’s announcements hit the headlines in the month of May. Donald Trump made impactful announcements pertaining to deregulations, trade relations with other countries and sanctions against countries like Iran and Venezuela. Overall, markets remained upbeat barring some occasional dips.
AGG IVV ELY QQQ IEF VOO SPY EZU IVV IWM EEM

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to SPY / SPDR S&P 500 ETF Trust on message board site Silicon Investor.

MDA - Market Direction Analysis MDA - Market Direction Analysis MDA - Market Direction Analysis Kirku0027s Market Thoughts Kirku0027s Market Thoughts Kirku0027s Market Thoughts
Technical analysis for shorts u0026 longs Technical analysis for shorts u0026 longs Technical analysis for shorts u0026 longs General market lab and commentary General market lab and commentary General market lab and commentary
Befriend the Trend Trading Befriend the Trend Trading Befriend the Trend Trading US Inflation and What To Do About It US Inflation and What To Do About It US Inflation and What To Do About It
WAR on Terror. Will it engulf the Entire Middle East? WAR on Terror. Will it engulf the Entire Middle East? WAR on Terror. Will it engulf the Entire Middle East? Catch_As_Catch_Can Charts and Other Stuff Catch_As_Catch_Can Charts and Other Stuff Catch_As_Catch_Can Charts and Other Stuff
trading diary trading diary trading diary Sector Charts Sector Charts Sector Charts
CUSIP: 78462F103